Every day, thousands of patients worldwide enter emergency departments with acute chest pain, shortness of breath or atypical symptoms. The differential diagnosis of acute coronary syndrome (ACS) is always one of the greatest challenges in emergency and cardiac medicine. The “2025 ACC/AHA/ACEP/NAEMSP/SCAI Guideline for the Management of Patients with Acute Coronary Syndromes”, published in February 2025, represents the most up-to-date, comprehensive consensus. The guideline guides the reader through the entire spectrum of care – from the initial prehospital ECG lead to long-term secondary prevention – and combines high-tech diagnostics with structured treatment algorithms to optimize the quality of care in each system. In the following article, we summarize the key recommendations, explain the scientific evidence behind them and provide tips for daily clinical practice.
You May Also Like
- Breast (HR+) and Endometrial Cancer
A Comparison of Hormone-Dependent Female Tumors
- Chronic Urticaria: Treatment for Patients Unresponsive to Antihistamines
In addition to anti-IgE antibodies, the guideline recommends anti-IL-4α antibodies and BTK inhibition
- Type 1 Diabetes in Childhood
Early Impairment of Glucagon Counterregulation
- Psychosis in Parkinson's Disease
Be Careful When Choosing Medications
- Esophageal Cancer
A Comparison of Endoscopic and Surgical Innovations
- PMR and LVV: Current EULAR Recommendations
Polymyalgia rheumatica, giant cell arteritis, and Takayasu arteritis
- Cellular and Systemic Iron Homeostasis
“Steady State” – a delicately balanced equilibrium
- Psychedelic-assisted therapy